To investigate whether MBC and FBC risk might be at least in part due to different genes, we then examined their mutability in a population of high-risk breast cancer women without BRCA1/BRCA2/PALB2 PV/LPV detected on the same 585-gene panel analysis. Here, PALB2 is linked to breast carcinoma.